D-0157-2026 Class III Ongoing
FDA drug recall D-0157-2026 was initiated by Imprimis NJOF, LLC on Oct 20, 2025 and is designated Class III. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 67,091 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 26, 2025
- Initiation Date
- Oct 20, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 67,091 bottles
Product description
Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852, NDC 71384-514-05
Reason for recall
Subpotent Drug
Distribution pattern
USA nationwide
Code information
Lot #:25JAN029, exp. date 07Nov2025; 25JAN042, exp. date 14Nov2025; 25JAN054, exp. date 21Nov2025; 25MAR021, exp. date 07Dec2025; 25APR017, exp. date 04Jan2026, 25APR025, exp. date 05Jan2026; 25MAY032, exp. date 31Jan2026; 25MAY055, exp. date 12Mar2026; 25MAY057, exp. date 14Mar2026; 25MAY073, exp. date 21Mar2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0157-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026